Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has entered into an agreement to acquire 60% shareholding in Vivaldis Health and Foods from its existing shareholders with remaining 40% shareholding to be acquired in future as per certain terms & conditions. Cost of acquisition is Rs 143.30 crore subject to customary closing adjustments for 60% shareholding. The said acquisition is expected to be completed by the end of May 2023.  

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.